TransAct Q2 net loss $319k on sales $11.6M (-42% YoY); guidance improved

TRANSACT TECHNOLOGIES INC

2024-Q2 EPS reported -$0.14 revenue$22,286,000

Q2 net sales $11.6M, down 42% YoY but up 9% sequentially from Q1 2024.
Net loss $(0.03)/share vs net income of $0.08/share in Q2 2023; adjusted net loss $(0.03)/share.
Sold 1,476 terminals (+64% sequential); FST recurring revenue $2.8M (+15% sequential, +12% YoY).
FY2024 guidance upgraded: net sales $45-50M, adj. EBITDA loss narrowed to $(1-2M) from $(2.5-3.5M).
Strategic business review ongoing with Roth Capital; discussions with outside parties continuing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.